• FAISL lncRNA Inhibits FAK Proteolysis to Drive TNBC Progress

  2026-06-04

  The reference study uncovers how the long noncoding RNA FAISL directly blocks Calpain 2-mediated cleavage of focal adhesion kinase (FAK), stabilizing FAK protein and promoting cell adhesion, proliferation, and metastasis in triple negative breast cancer (TNBC). This mechanistic insight highlights FAISL as a novel regulatory node and a promising therapeutic target for TNBC intervention.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Resp

  2026-06-03

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, better reflecting the complexity of the tumor microenvironment. The approach enables nuanced drug response studies, revealing the impact of stromal heterogeneity on resistance and supporting development of more predictive preclinical models.

• Ionomycin Free Acid: Precision Calcium Ionophore for Cell St

  2026-06-03

  Ionomycin free acid is a selective calcium ionophore that reliably increases intracellular Ca2+ by transporting ions across lipid membranes. This property enables precise modulation of calcium-dependent processes in vitro and in vivo, including oocyte activation and embryonic development. The compound is supplied by APExBIO with ≥95% purity and validated stability under recommended storage conditions.

• Artesunate: Applied Workflows for Advanced Cancer Research

  2026-06-02

  Artesunate, a high-purity artemisinin derivative, is redefining in vitro cancer drug profiling by enabling precise dissection of cell death mechanisms. This article delivers actionable workflows, troubleshooting strategies, and comparative insights for maximizing Artesunate’s impact in oncology research.

• ETS1 Regulates SUMOylation-Dependent Mitophagy in BPD Models

  2026-06-02

  The reference study identifies ETS1 as a transcriptional regulator that protects against bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 axis. This mechanistic insight highlights the therapeutic potential of targeting SUMOylation-dependent mitophagy in neonatal lung disease.

• Cyanine 5-dCTP in DNA Frameworks: Advancing EOS Precision

  2026-06-01

  Explore how Cyanine 5-dCTP redefines enzymatic oligonucleotide synthesis (EOS) by enabling high-fidelity, fluorescent DNA labeling within highly ordered DNA frameworks. This thought-leadership article merges mechanistic insight, strategic workflow guidance, and future-facing perspectives for translational researchers seeking to maximize nucleic acid detection and probe development. Anchored by recent advances in tetrahedral DNA nanostructures and competitive product intelligence, the discussion positions APExBIO’s Cy5-dCTP as a pivotal reagent in next-generation molecular biology.

• Polybrene (Hexadimethrine Bromide): Mechanistic Insights & E

  2026-06-01

  Explore the mechanistic foundation and advanced applications of Polybrene (Hexadimethrine Bromide) in viral gene delivery and peptide sequencing. This article offers a deep scientific perspective, evidence-based recommendations, and practical insights for optimizing assay performance.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src Kinase P

  2026-05-31

  Leverage 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) as an advanced negative control in Src kinase signaling studies to drive specificity and reproducibility. APExBIO's rigorously validated PP 3 streamlines kinase inhibitor workflows, ensuring robust discrimination of true Src-dependent effects from assay artifacts.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-30

  The referenced study uncovers that naturally occurring angiotensin peptides, particularly those resulting from N-terminal cleavage such as Angiotensin 1/2 (5-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide a mechanistic bridge between the renin-angiotensin system and viral pathogenesis, opening new research avenues for both cardiovascular and COVID-19-focused investigations.

• AZ505 SMYD2 Inhibitor: Precision Epigenetic Tools for Diseas

  2026-05-29

  AZ505, a potent and selective SMYD2 inhibitor from APExBIO, empowers researchers to dissect epigenetic regulation in cancer and fibrosis with unmatched specificity. This article translates cutting-edge findings into actionable workflows, troubleshooting guidance, and strategic comparisons for advanced applications in disease modeling.

• Coumestrol: Advancing SERM Science and RA Ferroptosis Models

  2026-05-29

  This thought-leadership article examines Coumestrol’s emerging value as a phytoestrogen estrogen receptor antagonist and selective ferroptosis inducer in rheumatoid arthritis (RA) research. Integrating mechanistic insights from recent literature with practical protocol guidance, it contextualizes Coumestrol’s role as a dual-action tool for translational researchers seeking robust, reproducible models in nuclear receptor modulation and inflammatory disease.

• Technical Guide: EdU Flow Cytometry Assay Kits (Cy5) for S-P

  2026-05-28

  The EdU Flow Cytometry Assay Kits (Cy5) provide a robust, denaturation-free method for quantifying S-phase DNA synthesis in proliferating cells using click chemistry. This product is best suited for workflows requiring sensitive cell proliferation analysis by flow cytometry, without compromising cell surface or intracellular antigen detection. It should not be used where direct BrdU-specific antibody detection or alternative nucleoside analogs are needed.

• Monomethyl Auristatin E: Optimizing ADC Payloads for Cancer

  2026-05-28

  Monomethyl auristatin E (MMAE) stands at the forefront of targeted cancer therapy, empowering researchers to engineer highly selective, potent antibody-drug conjugates (ADCs). This guide dives into advanced experimental workflows and troubleshooting strategies to fully leverage MMAE's unique mechanism and potent activity.

• Necrostatin 2: Precision Tools for Dissecting Necroptosis Me

  2026-05-27

  Explore how Necrostatin 2 (Nec-2) enables rigorous analysis of necroptosis pathways and RIPK2 signaling in disease models. This article delivers advanced, practical insights for designing robust experiments beyond conventional necroptosis inhibition studies.

• Alternariol: Mechanistic Insights and Translational Strategi

  2026-05-27

  Alternariol (AOH) is increasingly recognized as a pivotal mycotoxin in food safety and liver disease research. This thought-leadership article synthesizes emerging mechanistic findings with actionable guidance for translational researchers, highlighting how AOH drives hepatic fibrosis and apoptosis, the metabolic pathways involved, and the new opportunities for intervention and risk assessment. Drawing on recent omics-based studies and protocol advances, it positions APExBIO’s Alternariol as an essential tool for advancing mycotoxin research beyond traditional assays.

16211 records 1/1081 page Next 12345 下5页 Last page